Literature DB >> 9838718

A review of the epidemiology of psoriasis vulgaris in the community.

A Plunkett1, R Marks.   

Abstract

Standard diagnostic criteria for epidemiological studies of psoriasis are currently lacking. In their absence, clinical examination and diagnosis of psoriasis by dermatologists provides the gold standard to underpin epidemiological research in psoriasis. The methods of data collection used most frequently include cross-sectional studies, case-control studies, cohort studies, and surveys of hospital and private practice attendance. Estimates of psoriasis prevalence made in cross-sectional studies employing clinical examinations as the survey instrument have ranged from 0.3 to 2.5%. Psoriasis incidence has been estimated at 60.4 per 100,000 person years in one cohort study. Several factors have been identified as being associated either with causation of psoriasis or with triggering exacerbations or remissions, including genetic determinants, racial and regional variation, injury and infection, cigarette smoking, alcohol, diet and other diseases.

Entities:  

Mesh:

Year:  1998        PMID: 9838718     DOI: 10.1111/j.1440-0960.1998.tb01478.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  7 in total

1.  Association between psoriasis and incident cancer: the Iowa's Women's Health Study.

Authors:  Anna E Prizment; Alvaro Alonso; Aaron R Folsom; Rehana L Ahmed; Beth A Virnig; Erin M Warshaw; Kristin E Anderson
Journal:  Cancer Causes Control       Date:  2011-05-07       Impact factor: 2.506

2.  Rheumatic manifestations of psoriasis.

Authors:  H A Sadek; A M Abdel-Nasser; T A El-Amawy; S Z Hassan
Journal:  Clin Rheumatol       Date:  2006-05-03       Impact factor: 2.980

Review 3.  Classification and diagnostic criteria for psoriatic arthritis.

Authors:  P S Helliwell; W J Taylor
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

4.  Trends in incidence of adult-onset psoriasis over three decades: a population-based study.

Authors:  Murat Icen; Cynthia S Crowson; Marian T McEvoy; Frank J Dann; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  J Am Acad Dermatol       Date:  2009-03       Impact factor: 11.527

5.  Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation.

Authors:  Giorgio L Colombo; Sergio Di Matteo; Giacomo Bruno; Giampiero Girolomoni; Gino Antonio Vena
Journal:  Clinicoecon Outcomes Res       Date:  2012-09-13

6.  Moderate and severe plaque psoriasis: cost-of-illness study in Italy.

Authors:  Gl Colombo; Gf Altomare; K Peris; P Martini; G Quarta; M Congedo; A Costanzo; A Di Cesare; E Lapucci; S Chimenti
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

7.  Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris.

Authors:  Efstratios Vakirlis; Athanasios Kastanis; Demetrios Ioannides
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.